- Home
- FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), 25 mM HEPES w/o Glucose, L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), 25 mM HEPES w/o Glucose, L-Glutamine, Sodium Bicarbonate: 1X Liquid
FluxMPS™ DCP-DMEMH-GQB1X is a Microfluidics Suitable, ultra-filtered glucose-free DMEM + 25 mM HEPES formulation engineered for metabolic flux analysis, ¹³C isotope tracing, Warburg-effect research, and organ-on-a-chip applications where carbon source identity must be precisely controlled. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. Note: this formulation contains phenol red and is not recommended for Agilent Seahorse XF assays, which require phenol-red-free medium — contact us for the compatible variant. Formulation: [+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate | [-] Glucose, [-] L-Glutamine, [-] Sodium Bicarbonate.
- Glucose-free — add D-glucose, ¹³C-glucose, galactose, fructose, or any carbon source at your defined concentration
- 25 mM HEPES (pKa 7.3 at 37°C) — CO₂-independent pH stability; suited to open-top chips and metabolic sampling outside incubators
- Quadruple-stage filtration (0.1 µm ×2 + 0.04 µm ×2) to a 0.04 µm final cut-off for microchannel-safe purity
- Endotoxin release specification: < 0.05 EU/mL (LAL, USP <85>) for clean metabolic baselines
- Formulation: [+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate | [-] Glucose, [-] L-Glutamine, [-] Sodium Bicarbonate
- Contains phenol red as a visual pH indicator — for phenol-red-free imaging or Seahorse XF work, contact support@diagnocine.com for the compatible variant
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- Custom glucose concentrations, carbon sources, and nutrients available on request
- GlucoseNot included — researcher-defined
- HEPES25 mM (5958 mg/L), pKa 7.3 at 37°C
- Formulation[+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate | [-] Glucose, [-] L-Glutamine, [-] Sodium Bicarbonate
- AppearanceOrange-colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)310 - 350 mOsm/kg H₂O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Storage2–8°C, away from light
- Shelf Life12 months from date of manufacture, unopened
When carbon source control is the experiment
Standard DMEM contains a fixed glucose concentration that cannot be changed without switching media entirely. FluxMPS™ glucose-free DMEM + HEPES gives you a clean base formulation where every carbon source is added fresh at the concentration and identity you choose, while ultra-low particulate delivery supports chip integrity and a < 0.05 EU/mL endotoxin release specification helps avoid inflammatory artefacts in metabolic readouts.
Complete carbon source control
Add D-glucose, ¹³C-glucose, U-¹³C6-galactose, fructose, or no sugar. Combine with palmitate or other fatty acids. Define carbon source identity and concentration precisely for every experiment.
Metabolic flux & isotope tracing
Glucose-free base lets you add U-¹³C6-glucose, galactose, or fructose at defined specific activity for flux analysis, NMR metabolomics, and LC-MS/MS workflows without background dilution from endogenous glucose.
HEPES: CO₂-stable pH
25 mM HEPES (pKa 7.3 at 37°C) maintains pH 7.2–7.4 outside CO₂ incubators — useful for metabolic sampling and open-top chip platforms.
Microchannel-safe purity
0.04 µm final filtration and a < 0.05 EU/mL endotoxin release specification support clean metabolic baselines for glucose uptake, lactate, and OCR measurements.
Imaging-compatible variants
Phenol red–free options reduce autofluorescence and estrogen-receptor agonist activity for live-cell imaging, TEER, and biosensor OoC platforms. This SKU contains phenol red; contact us for a phenol-red-free variant.
Customization on demand
Custom glucose concentrations, carbon source additions, pH, and nutrient modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages reaching a final 0.04 µm polish under aseptic fill conditions — two dedicated prefilter + final-filter pairs run in series for redundant assurance.
-
1
0.1 µm Prefiltration I
Removes large aggregates and protein aggregates; protects the first 0.04 µm final filter from early fouling.
-
2
0.04 µm Final filtration I
Retains mycoplasma (0.2–0.3 µm) and fine particulates — not achievable with standard 0.22 µm filtration.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter protecting the second 0.04 µm cartridge, providing redundant assurance.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish.
Why filtration purity matters for metabolic assays
Elevated particulate counts and endotoxin are known to activate innate immune signalling (e.g., TLR4/NF-κB) that can upregulate glycolysis independently of experimental treatment, confounding glucose uptake, lactate production, and OCR measurements. FluxMPS™ DCP-DMEMH-GQB1X is manufactured to a batch release specification of < 0.05 EU/mL endotoxin (USP <85>) and processed through the Quadruple-stage filtration train described above.
© Diagnocine® — DCP-DMEMH-GQB1X
Metabolic research and OoC applications
FluxMPS™ DCP-DMEMH-GQB1X is purpose-built for experiments where carbon source identity must be controlled — from ¹³C metabolic flux analysis to glucose-dose response studies on organ-on-a-chip platforms.
Metabolic Flux Analysis & Isotope Tracing
Glucose-free DMEM + HEPES gives full control over carbon source identity for ¹³C metabolic flux analysis, Warburg-vs-OXPHOS switching studies, and NMR/LC-MS metabolomics workflows. The 25 mM HEPES buffer maintains stable pH during extended sample handling outside CO₂ incubators.
- ¹³C Isotope Tracing: Add U-¹³C6-glucose at exact specific activity without dilution from background glucose
- Warburg/OXPHOS Switching: Add glucose, galactose, or no sugar to control glycolytic vs. oxidative flux
- NMR & LC-MS Metabolomics: HEPES buffering supports stable pH during extended sample processing outside incubators
Inquiry Required: Custom glucose, galactose, or ¹³C-carbon source co-formulations available. Contact support@diagnocine.com.
¹³C Metabolic Flux Analysis
Add U-¹³C6-glucose at any specific activity without background dilution. HEPES maintains pH during NMR sample preparation outside incubators.
Warburg Effect & OXPHOS Switching
Add glucose (Warburg), galactose (force OXPHOS), or no sugar (starvation) to study metabolic flexibility in cancer lines without media changes.
Glucose Dose-Response on Chip
Perfuse defined glucose gradients through OoC channels to study dose-dependent metabolic responses in endothelial, beta-cell, or hepatocyte chips.
iPSC Metabolic Maturation
Glucose-free base enables galactose-forced OXPHOS maturation of iPSC-derived cardiomyocytes and hepatocytes, improving metabolic phenotype fidelity.
Nutrient Deprivation Studies
Starvation experiments, glucose withdrawal, and nutrient re-feeding protocols with defined timing and concentration control.
Metabolic Imaging & Biosensors
Phenol red–free variants reduce background autofluorescence for FLIM, NAD(P)H imaging, glucose FRET sensors, and TEER measurements on metabolic chips. This SKU contains phenol red.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Sodium Pyruvate | [-] Glucose, [-] L-Glutamine, [-] Sodium Bicarbonate |
| Appearance | Orange-colored, clear solution |
| Glucose | Not included — add at desired concentration |
| HEPES | 25 mM (5958 mg/L), pKa 7.3 at 37°C |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 310 - 350 mOsm/kg H₂O |
| Total ingredients | 31 (across 4 categories) |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (per-batch release spec — see §Manufacturing) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm / 0.04 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> | NMT 25/mL |
| Particulate ≥25 µm USP <788> | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO₂ requirement | CO₂-independent — HEPES (25 mM) alone maintains pH 7.2–7.4 at 37°C without gas supplementation |
| Pack sizes | 500 mL, 1000 mL |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
Glucose-free DMEM + HEPES scaffold: 31 ingredients verified per lot with CAS numbers, across 4 category groups. Glucose is intentionally absent — add your carbon source of choice. HEPES (25 mM = 5958 mg/L, CAS 7365-45-9) is listed under OTHERS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 30.000 |
| L-Arginine hydrochloride | 1119-34-2 | 84.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 62.570 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 105.000 |
| L-Leucine | 61-90-5 | 105.000 |
| L-Lysine hydrochloride | 657-27-2 | 146.000 |
| L-Methionine | 63-68-3 | 30.000 |
| L-Phenylalanine | 63-91-2 | 66.000 |
| L-Serine | 56-45-1 | 42.000 |
| L-Threonine | 72-19-5 | 95.000 |
| L-Tryptophan | 73-22-3 | 16.000 |
| L-Tyrosine Disodium Salt dihydrate | 69847-15-0 | 103.790 |
| L-Valine | 72-18-4 | 94.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 4.000 |
| D-Ca-Pantothenate | 137-08-6 | 4.000 |
| Folic acid | 59-30-3 | 4.000 |
| Nicotinamide | 98-92-0 | 4.000 |
| Pyridoxal hydrochloride | 65-22-5 | 4.000 |
| Riboflavin | 83-88-5 | 0.400 |
| Thiamine hydrochloride | 67-03-8 | 4.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 7.200 |
| Phenol red sodium salt | 34487-61-1 | 15.900 |
| Sodium pyruvate | 113-24-6 | 110.000 |
| HEPES | 7365-45-9 | 5958.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a rigorous multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016-certified quality management system. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm Type 1 water supports low trace-metal and organic-carbon background for metabolic flux measurements.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending between batches, Certificate of Analysis for every lot.
Endotoxin — USP <85> BET
LAL assay; batch release specification < 0.05 EU/mL.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 310 - 350 mOsm/kg H₂O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-DMEMH-GQB1X compares
FluxMPS™ DCP-DMEMH-GQB1X vs. conventional glucose-free DMEM and standard DMEM for metabolic assays.
| Parameter | DCP-DMEMH-GQB1X (FluxMPS™) | Conventional GF-DMEM (0.22 µm filtered) |
Standard DMEM (fixed glucose, 0.22 µm) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| Glucose-free DMEM + HEPES — no Glucose, no L-Glutamine, no Sodium Bicarbonate; CO₂-independent pH | check_circle Yes | cancel No | cancel No |
| Glucose content | None — researcher-defined | None | Fixed (1–4.5 g/L) |
| HEPES (25 mM) | check_circle Yes | cancel Usually no | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (0.1 µm ×2 + 0.04 µm ×2) | 1 | 1 |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes | cancel No | cancel No |
| Mycoplasma barrier filtration | check_circle Yes (0.1/0.04 µm) | cancel No | cancel No |
| Water quality | Ultrapure Type 1, 18.2 MΩ·cm | Not specified | Not specified |
| Agilent Seahorse XF compatible | cancel No — contains phenol red | check_circle Typically yes (phenol-red-free) | cancel Fixed carbon source |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Custom formulation | check_circle Available | cancel Fixed | cancel Fixed |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-DMEMH-GQB1X glucose-free DMEM + 25 mM HEPES.
Supporting literature
Key publications supporting glucose-free DMEM in metabolic flux analysis, isotope tracing, and organ-on-a-chip metabolic studies.
- Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi:10.1126/science.123.3191.309
- Jain M, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012;336:1040–1044. doi:10.1126/science.1218595
- Birsoy K, et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell. 2015;162:540–551. doi:10.1016/j.cell.2015.07.016
- Sullivan LB, et al. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell. 2015;162:552–563. doi:10.1016/j.cell.2015.07.017
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Schell JC, et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell. 2014;56:400–413. doi:10.1016/j.molcel.2014.09.026
- Faubert B, et al. Lactate metabolism in human lung tumors. Cell. 2017;171:358–371. doi:10.1016/j.cell.2017.09.019
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x


